Evidence map›Paper›PMID 32881862›Full record

ArticlePLoS neglected tropical diseases2020

A new Korean Research Investment for Global Health Technology (RIGHT) Fund to advance innovative neglected-disease technologies.

Peter J Hotez, Kim Bush, Andrin Oswald, Glenn Rockman, In-Taek Lim, Youngmee Jee, Chang Jin Moon, Jerome H Kim, Younbeen Kim

Abstract readEditorial
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. World neglected tropical diseases day.PLoS neglected tropical diseases · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Peter J HotezRIGHT Fund, Seoul, Republic of Korea.ORCID 0000-0001-8770-1042
Kim BushRIGHT Fund, Seoul, Republic of Korea.
Andrin OswaldRIGHT Fund, Seoul, Republic of Korea.
Glenn RockmanRIGHT Fund, Seoul, Republic of Korea.ORCID 0000-0003-4260-9378
In-Taek LimRIGHT Fund, Seoul, Republic of Korea.
Youngmee JeeRIGHT Fund, Seoul, Republic of Korea.
Chang Jin MoonRIGHT Fund, Seoul, Republic of Korea.
Jerome H KimInternational Vaccine Institute (IVI), Seoul, Republic of Korea.
Younbeen KimRIGHT Fund, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2018, the government of the Republic of Korea (ROK), South Korean life science companies, and a group of international funders led by the Bill & Melinda Gates Foundation launched a new and innovative funding agency to support neglected-disease research and development (R&D). The new venture is known as the Research Investment for Global Health Technology (RIGHT) Fund.

Indexed as

Biomedical TechnologyFinancial ManagementGlobal HealthHumansNeglected DiseasesRepublic of Korea

Identifiers

PMID32881862
PMCPMC7470318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.